Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
- PMID: 22143677
- DOI: 10.1007/s00417-011-1884-5
Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
Comment on
-
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):401-2. doi: 10.1007/s00417-011-1883-6. Epub 2011 Dec 10. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 22160507 No abstract available.
Similar articles
-
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):401-2. doi: 10.1007/s00417-011-1883-6. Epub 2011 Dec 10. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 22160507 No abstract available.
-
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1159-66. doi: 10.1007/s00417-011-1651-7. Epub 2011 Mar 30. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21448811
-
Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.Eye (Lond). 2016 Jun;30(6):805-11. doi: 10.1038/eye.2016.41. Epub 2016 Mar 11. Eye (Lond). 2016. PMID: 26965012 Free PMC article.
-
System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Acta Ophthalmol. 2014 Dec;92(8):e594-601. doi: 10.1111/aos.12482. Epub 2014 Jul 13. Acta Ophthalmol. 2014. PMID: 25042260 Review.
-
Photosensitizers and Photodynamic Therapy: Verteporfin.Dev Ophthalmol. 2016;55:330-6. doi: 10.1159/000434704. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501167 Review.
Cited by
-
Interventions for central serous chorioretinopathy: a network meta-analysis.Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3. Cochrane Database Syst Rev. 2025. PMID: 40522203
-
Interventions for central serous chorioretinopathy: a network meta-analysis.Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD011841. doi: 10.1002/14651858.CD011841.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Jun 16;6:CD011841. doi: 10.1002/14651858.CD011841.pub3. PMID: 26691378 Free PMC article. Updated.
-
Alternating central serous chorioretinopathy in two consecutive pregnancies.Oman J Ophthalmol. 2014 May;7(2):87-9. doi: 10.4103/0974-620X.137169. Oman J Ophthalmol. 2014. PMID: 25136236 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources